What to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read More
Biosimilar Approval and Adoption Challenges
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Read More
Uncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read More
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read More
How to have a data-driven discussion on gene and cellular therapies
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Read More
Understanding gene modification and cellular therapies
Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology
Read More